Skip to main content
. Author manuscript; available in PMC: 2014 Sep 18.
Published in final edited form as: Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007076. doi: 10.1002/14651858.CD007076.pub2

Figure 3. Percentage of participants with at least 50% pain relief with placebo or four daily pregabalin doses at trial end in four painful conditions.

Figure 3